Amneal Pharmaceuticals (AMRX) Exchange Rate Effect (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded quarterly Exchange Rate Effect of -$1.0 million in Q1 2026, down 389.47% quarter-over-quarter from -$209000.0 in Q4 2025, and down 117.66% on a YoY basis from $5.8 million in Q1 2025.
Amneal Pharmaceuticals (AMRX) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Exchange Rate Effect history runs 10 years deep, the most recent figure standing at -$1.0 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 117.66% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$2.2 million (down 71.24% YoY), while the FY2025 annual figure was -$1.7 million, down 68.17% from the prior year.
- Exchange Rate Effect was -$1.0 million for Q1 2026 at Amneal Pharmaceuticals, down from -$209000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $767000.0 in Q1 2023 to a low of -$3.7 million in Q4 2022.
- Historically, Exchange Rate Effect has averaged -$548235.3 across 5 years, with a median of -$307000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Exchange Rate Effect surged 148.79% in 2023, then slumped 10014.29% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$3.7 million in 2022, then jumped by 105.38% to $201000.0 in 2023, then sank by 468.16% to -$740000.0 in 2024, then soared by 71.76% to -$209000.0 in 2025, then sank by 389.47% to -$1.0 million in 2026.
- The last three Exchange Rate Effect figures came in at -$1.0 million (Q1 2026), -$209000.0 (Q4 2025), and -$694000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Amneal Pharmaceuticals | 4.34 Bn | 4.33 Bn | 320.11 Mn | -1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.02 Mn |
| Mar 31, 2026 | -1.02 Mn |
| Dec 31, 2025 | -209,000.00 |
| Dec 31, 2025 | -209,000.00 |
| Sep 30, 2025 | -694,000.00 |
| Sep 30, 2025 | -694,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Mar 31, 2025 | -470,000.00 |
| Mar 31, 2025 | -470,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | -165,000.00 |
| Mar 31, 2024 | -165,000.00 |
| Dec 31, 2023 | 201,000.00 |
| Dec 31, 2023 | 201,000.00 |